Epigenetics and Gene Regulation in Disease

Epigenetics is the study of heritable or persistent changes in gene activity that do not alter the underlying DNA sequence. Mechanisms such as DNA methylation, histone modification, chromatin remodelling, and non-coding RNAs control which genes are expressed in a given cell, and their dysregulation contributes to disease — most prominently to cancer, but also to developmental, metabolic, and neurological disorders. Because epigenetic marks are potentially reversible, they are of distinct interest in disease biology.

Definition

Epigenetics concerns mitotically (and sometimes meiotically) heritable changes in gene expression that occur without alteration of the DNA sequence, mediated chiefly by DNA methylation, histone modification, chromatin structure, and non-coding RNAs; epigenetic dysregulation refers to the disturbance of these mechanisms in disease.

Scope

This topic covers the principal epigenetic mechanisms, how they establish and maintain cell-type-specific gene expression, and how their disturbance contributes to disease, with cancer epigenetics as the best-characterized example and developmental programming as a second major theme. It is a mechanistic reference; it does not discuss epigenetic therapies or testing for individual care.

Core questions

• How do DNA methylation and histone modifications regulate gene expression without changing the DNA sequence?
• How are epigenetic states established during development and maintained through cell division?
• How does epigenetic dysregulation contribute to cancer and other diseases?
• In what sense are epigenetic changes reversible, and how does that distinguish them from genetic mutations?

Key concepts

• DNA methylation
• Histone modification
• Chromatin remodelling
• Non-coding RNA regulation
• Genomic imprinting
• Epigenetic memory and heritability through cell division
• Hypermethylation and gene silencing
• Developmental programming

Mechanisms

Gene expression is shaped by reversible modifications layered on DNA and its packaging proteins. DNA methylation, typically at CpG sites, is associated with transcriptional silencing when it occurs at promoter regions; covalent histone modifications and ATP-dependent chromatin remodelling alter how tightly DNA is packaged and therefore how accessible genes are; and non-coding RNAs add further regulatory control. These marks are copied during cell division, giving epigenetic memory that maintains cell identity. In disease, this regulation is disturbed: in cancer, for example, global hypomethylation coexists with promoter hypermethylation that silences tumour-suppressor genes, alongside altered histone patterns. Early-life environmental conditions can also shape epigenetic states in ways linked to later disease risk, the basis of developmental programming.

Clinical relevance

Epigenetic mechanisms explain how cells with identical genomes maintain distinct identities and how gene regulation can go wrong in disease, informing pathology's understanding of cancer and developmental disorders. This entry describes mechanisms for reference; it does not address epigenetic biomarkers or therapies for use in individual diagnosis or treatment.

Epidemiology

Epigenetic alterations are a near-universal feature of human cancers and are described across developmental, metabolic, and neurological conditions; because epigenetic states vary by tissue, age, and environment, their distribution is studied per disease and cell type rather than as a single population frequency.

History

Waddington coined 'epigenetics' in the mid-twentieth century to describe how genotype produces phenotype during development. The later identification of DNA methylation and histone modification as molecular carriers of gene-regulatory information, and the recognition from the 1980s onward that these are disturbed in cancer, established epigenetics as central to disease biology, with the developmental-origins framework extending it to long-term disease risk.

Key figures

• Conrad Waddington
• Adrian Bird
• Peter Jones
• Stephen Baylin

Seminal works

• bird-2002
• jones-2007
• gluckman-2008

Frequently asked questions

How is an epigenetic change different from a genetic mutation?

A genetic mutation alters the DNA sequence itself, whereas an epigenetic change alters how genes are switched on or off without changing the sequence. Epigenetic marks can be maintained through cell division yet are, in principle, reversible, unlike a fixed sequence mutation.

Why is epigenetics especially important in cancer?

Cancer cells typically show widespread epigenetic disturbances, such as methylation that silences tumour-suppressor genes alongside altered histone patterns, which change gene expression and contribute to tumour development independently of, or together with, DNA mutations.